Blue chips dragged by AstraZeneca, Apple iPhone 16 met with a shrug By Proactive Investors Blue chips dragged by AstraZeneca, Apple iPhone 16 met with a shrug…
FTSE 100 dips as AstraZeneca weighs, Centamin takeover lifts precious metals miners The FTSE 100 dipped on Tuesday as AstraZeneca weighed on the index after announcing disappointing developments for a lung cancer…
AstraZeneca Defends China Compliance In Wake of Staff Detentions AstraZeneca Plc has strong compliance policies in China and is working closely with authorities following the detention of several employees…
AstraZeneca shares fall 5% on disappointing lung cancer drug trial results AstraZeneca shares fell more than 5% Tuesday morning, the biggest one-day drop in seven months, after the British pharmaceutical giant…
AstraZeneca shares down on disappointing drug trial results By Investing.com AstraZeneca shares down on disappointing drug trial results…